These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma. Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084 [TBL] [Abstract][Full Text] [Related]
23. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma. Jia HL; Ye QH; Qin LX; Budhu A; Forgues M; Chen Y; Liu YK; Sun HC; Wang L; Lu HZ; Shen F; Tang ZY; Wang XW Clin Cancer Res; 2007 Feb; 13(4):1133-9. PubMed ID: 17317821 [TBL] [Abstract][Full Text] [Related]
25. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823 [TBL] [Abstract][Full Text] [Related]
26. [Expression of two types of melanoma antigens in hepatocellular carcinoma]. Cai S; Leng X; Wang Y Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):205-7. PubMed ID: 11783086 [TBL] [Abstract][Full Text] [Related]
27. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction. Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805 [TBL] [Abstract][Full Text] [Related]
28. Ribosome Profiling of Vaccinia Virus-Infected Cells. Lin Y; Qiao W; Yang Z Methods Mol Biol; 2019; 2023():171-188. PubMed ID: 31240678 [TBL] [Abstract][Full Text] [Related]
29. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Xu L; Hui L; Wang S; Gong J; Jin Y; Wang Y; Ji Y; Wu X; Han Z; Hu G Cancer Res; 2001 Apr; 61(7):3176-81. PubMed ID: 11306505 [TBL] [Abstract][Full Text] [Related]
30. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma. Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000 [TBL] [Abstract][Full Text] [Related]
31. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation. Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis. Wu HY; Cai KT; Ma J; Chen G; Dang YW; Lu HP; Pan SL Pathol Res Pract; 2019 Jul; 215(7):152424. PubMed ID: 31103408 [TBL] [Abstract][Full Text] [Related]
33. Expression of the nonclassical HLA class I and MICA/B molecules in human hepatocellular carcinoma. Chen A; Shen Y; Xia M; Xu L; Pan N; Yin Y; Miao F; Shen C; Xie W; Zhang J Neoplasma; 2011; 58(5):371-6. PubMed ID: 21744989 [TBL] [Abstract][Full Text] [Related]
34. Translational implication of Kallmann syndrome-1 gene expression in hepatocellular carcinoma. Tanaka Y; Kanda M; Sugimoto H; Shimizu D; Sueoka S; Takami H; Ezaka K; Hashimoto R; Okamura Y; Iwata N; Tanaka C; Yamada S; Fujii T; Nakayama G; Koike M; Nomoto S; Fujiwara M; Kodera Y Int J Oncol; 2015; 46(6):2546-54. PubMed ID: 25892360 [TBL] [Abstract][Full Text] [Related]
35. HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer. Zhu H; Berkova Z; Mathur R; Sehgal L; Khashab T; Tao RH; Ao X; Feng L; Sabichi AL; Blechacz B; Rashid A; Samaniego F Mol Cancer Res; 2015 May; 13(5):809-18. PubMed ID: 25678597 [TBL] [Abstract][Full Text] [Related]
36. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers. Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793 [TBL] [Abstract][Full Text] [Related]
37. Expression of connective tissue growth factor in the livers of non-viral hepatocellular carcinoma patients with metabolic risk factors. Akahoshi K; Tanaka S; Mogushi K; Shimada S; Matsumura S; Akiyama Y; Aihara A; Mitsunori Y; Ban D; Ochiai T; Kudo A; Arii S; Tanabe M J Gastroenterol; 2016 Sep; 51(9):910-22. PubMed ID: 26739296 [TBL] [Abstract][Full Text] [Related]
38. Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma. Tremblay MP; Armero VE; Allaire A; Boudreault S; Martenon-Brodeur C; Durand M; Lapointe E; Thibault P; Tremblay-Létourneau M; Perreault JP; Scott MS; Bisaillon M BMC Genomics; 2016 Aug; 17(1):683. PubMed ID: 27565572 [TBL] [Abstract][Full Text] [Related]
39. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study. Wang Y; Huang Q; Deng T; Li BH; Ren XQ Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068 [TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma. Jin Y; Lee WY; Toh ST; Tennakoon C; Toh HC; Chow PK; Chung AY; Chong SS; Ooi LL; Sung WK; Lee CG J Transl Med; 2019 Aug; 17(1):273. PubMed ID: 31429776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]